Joseph M. Mahady
Präsident bei Elan Corp. Plc /Abelcet North American Operations/
Profil
Joseph M.
Mahady is currently the President of Elan Corp.
Plc since 2001.
He was the Chairman of AMAG Pharma USA, Inc. from 2013 to 2014 and an Independent Director of Albemarle Corp.
from 2012 to 2015.
He was also a Director of Immunex Corp., Windtree Therapeutics, Inc., EKR Therapeutics, Inc., Cortendo AB, and Project HOPE-The-People-To-People Health Foundation, Inc. He served as the President of Wyeth LLC in 2009 and was the President of Wyeth Pharmaceuticals LLC from 1997 to 2009.
He was also the President of Wyeth-Ayerst International LLC.
Mr. Mahady holds an MBA from Fairleigh Dickinson University and an undergraduate degree from the College of Pharmacy & Health Sciences.
Aktive Positionen von Joseph M. Mahady
| Unternehmen | Position | Beginn |
|---|---|---|
| Elan Corp. Plc /Abelcet North American Operations/ | Präsident | 01.06.2001 |
Ehemalige bekannte Positionen von Joseph M. Mahady
| Unternehmen | Position | Ende |
|---|---|---|
| WINDTREE THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 03.02.2021 |
| STRONGBRIDGE BIOPHARMA | Direktor/Vorstandsmitglied | 15.09.2015 |
| ALBEMARLE CORPORATION | Direktor/Vorstandsmitglied | 12.01.2015 |
AMAG Pharma USA, Inc.
 AMAG Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharma USA, Inc. engages in the provision of pharmaceutical products to independent pharmacies, managed care organizations, hospitals, pharmacy benefit management companies, government entities, and physicians. The company was founded by Victor M. Hermelin in 1942 and is headquartered in Waltham, MA. | Vorsitzender | 01.01.2014 |
EKR Therapeutics, Inc.
 EKR Therapeutics, Inc. Hospital/Nursing ManagementHealth Services EKR Therapeutics, Inc. is a specialty pharmaceutical company focused on acquiring, developing and maximizing the potential utility of critical-care hospital products offering broader therapeutic options and greater control to improve in-patient care, speed recovery, and achieve optimal outcomes. Backed by the strength of its award winning management team, the dedication of its field force of product specialists and its commitment to excellence in customer service and medical education, EKR has been organized to be a class leader in commercializing products to address unmet and under-satisfied medical needs or to otherwise enhance the therapeutic value of acute-care products. | Direktor/Vorstandsmitglied | 03.10.2012 |
Ausbildung von Joseph M. Mahady
| Fairleigh Dickinson University | Masters Business Admin |
| College of Pharmacy & Health Sciences | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ALBEMARLE CORPORATION | Process Industries |
| WINDTREE THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 10 |
|---|---|
| Elan Corp. Plc /Abelcet North American Operations/ | Health Technology |
Wyeth Pharmaceuticals LLC
 Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Health Technology |
Project HOPE-The-People-To-People HealthFoundation, Inc.
 Project HOPE-The-People-To-People HealthFoundation, Inc. Medical/Nursing ServicesHealth Services Project HOPE-The-People-To-People HealthFoundation, Inc. provides solutions to health problems. The firm trains health professionals and build medical facilities in areas devastated by conflict, natural disasters, and poverty. It addresses infectious diseases, health professional education, women's and children's health, humanitarian assistance, and the need for health systems and facilities. The company was founded by William B. Walsh in 1958 and is headquartered in Millwood, VA. | Health Services |
EKR Therapeutics, Inc.
EKR Therapeutics, Inc. Hospital/Nursing ManagementHealth Services EKR Therapeutics, Inc. is a specialty pharmaceutical company focused on acquiring, developing and maximizing the potential utility of critical-care hospital products offering broader therapeutic options and greater control to improve in-patient care, speed recovery, and achieve optimal outcomes. Backed by the strength of its award winning management team, the dedication of its field force of product specialists and its commitment to excellence in customer service and medical education, EKR has been organized to be a class leader in commercializing products to address unmet and under-satisfied medical needs or to otherwise enhance the therapeutic value of acute-care products. | Health Services |
AMAG Pharma USA, Inc.
AMAG Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharma USA, Inc. engages in the provision of pharmaceutical products to independent pharmacies, managed care organizations, hospitals, pharmacy benefit management companies, government entities, and physicians. The company was founded by Victor M. Hermelin in 1942 and is headquartered in Waltham, MA. | Health Technology |
Cortendo AB
 Cortendo AB Miscellaneous Commercial ServicesCommercial Services Cortendo AB engages in the provision of biopharmaceutical business. Its activities include development and distribution of orphan drugs for metabolic and endocrine diseases as well as diabetes. Its products include cortisol inhibition and normocort. The company was founded on October 6, 1996 and is headquartered in Trevose, PA. | Commercial Services |
Immunex Corp.
 Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Health Technology |
| Wyeth-Ayerst International LLC | |
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Health Technology |
Strongbridge Biopharma Plc
 Strongbridge Biopharma Plc Pharmaceuticals: MajorHealth Technology Strongbridge Biopharma Plc operates as a commercial-stage biopharmaceutical company, which focuses on the development and commercialization of therapies for rare diseases. Its pipeline is comprised of Keveyis, Macrilen, Recorlev, and Veldoreotide. The company was founded in 1996 and is headquartered in Trevose, PA. | Health Technology |
